Table 4 Characteristics of patient with different PRS
Variable | Low-risk (n = 29) | Intermediate-risk (n = 201) | High-risk (n = 78) |
|---|---|---|---|
Age (year), median (range) | 46.3 (29–73) | 47.6 (19–74) | 47.0 (24–72) |
Tumor diameter (cm), median (range) | 2.2 (0.2–3.8) | 4.2 (1.1–10.0) | 4.5 (1.5–10.0) |
< 4 | 29 (100%) | 73 (36.3%) | 29 (37.2%) |
≥ 4 | – | 107 (53.2%) | 42 (53.8%) |
NA | – | 21 (10.4%) | 7 (9.0%) |
SCCA (ng/ml), median (range) | 1.479 (0.40–6.60) | 8.04 (0.30–70.00) | 13.13 (0.50–70.00) |
2009 FIGO Stage | |||
IA2-IB2 | 21 (72.4%) | 72 (35.8%) | 28 (35.9%) |
IIA1-IIA2 | 8 (27.6%) | 129 (64.2%) | 50 (54.1%) |
SUVmax, median (range) | 9.97 (3.03–28.44) | 14.08 (2.65–71.84) | 13.43 (2.65–37.41) |
MTV, median (range) | 14.06 (0.28–36.49) | 49.15 (0.41–263.37) | 61.17 (0.41–263.37) |
TLG, median (range) | 66.83 (0.76–277.49) | 326.69 (1.05–2183.34) | 394.56 (1.05–2183.34) |